The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease

Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pa...

Full description

Saved in:
Bibliographic Details
Published inJournal of Nuclear Medicine Vol. 59; no. 9; pp. 1437 - 1444
Main Authors Meles, Sanne K., Renken, Remco J., Janzen, Annette, Vadasz, David, Pagani, Marco, Arnaldi, Dario, Morbelli, Silvia, Nobili, Flavio, Mayer, Geert, Leenders, Klaus L., Oertel, Wolfgang H.
Format Journal Article
LanguageEnglish
Published United States Society of Nuclear Medicine 01.09.2018
Subjects
Online AccessGet full text
ISSN0161-5505
1535-5667
2159-662X
2159-662X
1535-5667
DOI10.2967/jnumed.117.202242

Cover

Abstract Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients. The iRBD-related pattern was identified in F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms. The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls ( < 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition ( = 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP ( = 0.94, < 0.0001). Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity.
AbstractList Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients. The iRBD-related pattern was identified in F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms. The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls ( < 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition ( = 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP ( = 0.94, < 0.0001). Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity.
Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of 18F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients. Methods: The iRBD-related pattern was identified in 18F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in 18F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms. Results: The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls (P < 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition (P = 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP (r = 0.94, P < 0.0001). Conclusion: Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity.Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of 18F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients. Methods: The iRBD-related pattern was identified in 18F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in 18F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms. Results: The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls (P < 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition (P = 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP (r = 0.94, P < 0.0001). Conclusion: Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity.
Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance analysis of 18F-FDG PET data has disclosed a specific brain pattern of altered glucose metabolism in PD. In this study, we identify the metabolic pattern underlying iRBD and compare it with the known PD pattern. To understand the relevance of the iRBD pattern to disease progression, we studied the expression of the iRBD pattern in de novo PD patients. Methods: The iRBD-related pattern was identified in 18F-FDG PET scans of 21 patients with polysomnographically confirmed iRBD and 19 controls using spatial covariance analysis. Expression of the iRBD-related pattern was subsequently computed in 18F-FDG PET scans of 44 controls and 38 de novo, treatment-naïve PD patients. Of these 38 PD patients, 24 had probable REM sleep behavior disorder (RBD) according to the Mayo Sleep Questionnaire. Neuropsychologic evaluation showed mild cognitive impairment in 20 PD patients (PD-MCI), of whom 16 also had concomitant RBD and roughly half (11/20) had bilateral motor symptoms. Results: The iRBD-related pattern was characterized by relative hypermetabolism in the cerebellum, brain stem, thalamus, sensorimotor cortex, and hippocampus, and by relative hypometabolism in the middle cingulate, temporal, occipital, and parietal cortices. This topography partially overlapped with the PD-related pattern (PDRP). The iRBD-related pattern was significantly expressed in PD patients compared with controls (P < 0.0001). iRBD-related pattern expression was not significantly different between PD patients with and without probable RBD, or between PD patients with unilateral or bilateral parkinsonism. iRBD-related pattern (iRBDRP) expression was higher in PD-MCI patients than in PD patients with preserved cognition (P = 0.001). Subject scores on the iRBD-related pattern were highly correlated to subject scores on the PDRP (r = 0.94, P < 0.0001). Conclusion: Our results show that the iRBDRP is an early manifestation of the PDRP. Expression of both PDRP and iRBDRP was higher in patients with a more severe form of PD (PD-MCI), which indicates that expression of the 2 patterns increases with disease severity.
Author Janzen, Annette
Pagani, Marco
Mayer, Geert
Renken, Remco J.
Vadasz, David
Oertel, Wolfgang H.
Meles, Sanne K.
Morbelli, Silvia
Nobili, Flavio
Leenders, Klaus L.
Arnaldi, Dario
Author_xml – sequence: 1
  givenname: Sanne K.
  surname: Meles
  fullname: Meles, Sanne K.
– sequence: 2
  givenname: Remco J.
  surname: Renken
  fullname: Renken, Remco J.
– sequence: 3
  givenname: Annette
  surname: Janzen
  fullname: Janzen, Annette
– sequence: 4
  givenname: David
  surname: Vadasz
  fullname: Vadasz, David
– sequence: 5
  givenname: Marco
  surname: Pagani
  fullname: Pagani, Marco
– sequence: 6
  givenname: Dario
  surname: Arnaldi
  fullname: Arnaldi, Dario
– sequence: 7
  givenname: Silvia
  surname: Morbelli
  fullname: Morbelli, Silvia
– sequence: 8
  givenname: Flavio
  surname: Nobili
  fullname: Nobili, Flavio
– sequence: 9
  givenname: Geert
  surname: Mayer
  fullname: Mayer, Geert
– sequence: 10
  givenname: Klaus L.
  surname: Leenders
  fullname: Leenders, Klaus L.
– sequence: 11
  givenname: Wolfgang H.
  surname: Oertel
  fullname: Oertel, Wolfgang H.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29476004$$D View this record in MEDLINE/PubMed
BookMark eNqNkE1v1DAQhi1URLdLfwAXFIlLL1lsJ7HjI5QtVGoFaovUWzRxJqwXrx1sp9X-e7JKe-kBcRpp9Lzz8ZyQI-cdEvKO0RVXQn7cunGH3YoxueKU85K_IgvOKpULwe-PyIIywfKqotUxOYlxSykVdV2_IcdclVJQWi5If7fB7BoTtN4anf2AlDC4zPfZZWf8AGkzdW_W19mtRRyyz7iBB-ND9sVEHzoM2Q32FnWK2RqC3ee3CX7hNCb8Ni56d-AQIr4lr3uwEU-f6pL8vFjfnX_Lr75_vTz_dJXrQvKUV4KpFnrZM9YpLtpO1KqsQTLZaQpYtLxQqip5X4sOZCEKAOgRqVal4J3UxZLwee7oBtg_grXNEMwOwr5htDlIa2ZpzSStmaVNobM5NAT_Z8SYmp2JGq0Fh36ME0alqrma9i3Jhxfo1o_BTS81nHFRiYLxeqLeP1Fje9j1fMKz9glgM6CDjzFg_19XyhcZbRIk410KYOw_kn8BCVaoZA
CitedBy_id crossref_primary_10_3233_JPD_181468
crossref_primary_10_1002_mds_30126
crossref_primary_10_1186_s40035_023_00356_y
crossref_primary_10_1016_j_dadm_2019_04_002
crossref_primary_10_1038_s41531_024_00813_z
crossref_primary_10_1159_000533297
crossref_primary_10_1007_s10072_019_04118_5
crossref_primary_10_1002_mds_27823
crossref_primary_10_1002_jnr_70029
crossref_primary_10_1007_s10072_023_06829_2
crossref_primary_10_1111_acer_14158
crossref_primary_10_3390_brainsci12091248
crossref_primary_10_3389_fneur_2019_01204
crossref_primary_10_1186_s10020_021_00327_x
crossref_primary_10_1007_s00415_020_10271_1
crossref_primary_10_1016_j_sleep_2020_01_010
crossref_primary_10_1080_13803395_2019_1623180
crossref_primary_10_1515_revneuro_2018_0061
crossref_primary_10_1016_j_sleep_2024_06_024
crossref_primary_10_1111_ene_14215
crossref_primary_10_1002_mds_28592
crossref_primary_10_1038_s41531_024_00685_3
crossref_primary_10_1111_jsr_13880
crossref_primary_10_1212_WNL_0000000000210077
crossref_primary_10_1177_0271678X19828916
crossref_primary_10_3389_fneur_2020_563624
crossref_primary_10_1038_s41531_023_00557_2
crossref_primary_10_3389_fneur_2022_1009907
crossref_primary_10_1007_s00702_019_02001_3
crossref_primary_10_1007_s13311_020_00994_4
crossref_primary_10_1093_braincomms_fcad021
crossref_primary_10_3389_fnins_2022_930735
crossref_primary_10_1002_mds_29236
crossref_primary_10_1007_s00259_023_06289_y
crossref_primary_10_1093_sleep_zsae052
crossref_primary_10_1016_j_sleep_2024_12_003
crossref_primary_10_1007_s11682_021_00615_4
crossref_primary_10_1038_s41467_024_54695_z
crossref_primary_10_1080_14737175_2019_1640603
crossref_primary_10_1093_sleep_zsaa199
crossref_primary_10_3233_JPD_230385
crossref_primary_10_1007_s00702_024_02846_3
crossref_primary_10_1016_j_nicl_2020_102294
crossref_primary_10_1016_j_ynirp_2021_100026
crossref_primary_10_3390_brainsci11040433
crossref_primary_10_3988_jcn_2019_15_2_175
crossref_primary_10_1212_WNL_0000000000210105
crossref_primary_10_1002_mds_28859
crossref_primary_10_1016_j_parkreldis_2019_03_017
crossref_primary_10_1007_s11910_022_01171_0
crossref_primary_10_1002_mds_29188
crossref_primary_10_1212_WNL_0000000000208015
crossref_primary_10_1142_S0129065719500102
crossref_primary_10_1002_mds_27960
crossref_primary_10_2967_jnumed_124_268754
crossref_primary_10_1007_s00259_021_05205_6
crossref_primary_10_1093_sleep_zsae308
crossref_primary_10_1016_S1474_4422_18_30169_8
crossref_primary_10_1016_S1474_4422_21_00030_2
crossref_primary_10_1016_S1474_4422_21_00176_9
crossref_primary_10_1093_sleep_zsab232
crossref_primary_10_3390_jpm11090880
crossref_primary_10_1007_s41105_024_00568_3
crossref_primary_10_3233_JAD_220653
crossref_primary_10_1007_s11065_022_09572_1
crossref_primary_10_1016_j_nicl_2023_103475
crossref_primary_10_3233_JPD_202117
crossref_primary_10_1038_s41531_024_00800_4
crossref_primary_10_1038_s41531_023_00532_x
crossref_primary_10_7759_cureus_17026
crossref_primary_10_1016_j_sleep_2024_03_012
crossref_primary_10_1002_mds_29012
crossref_primary_10_1002_mds_29177
crossref_primary_10_1016_j_parkreldis_2021_07_022
crossref_primary_10_1002_mds_29138
crossref_primary_10_1038_s41582_022_00753_3
Cites_doi 10.1016/j.neuroimage.2009.06.012
10.1212/01.wnl.0000242879.39415.49
10.1016/S1474-4422(11)70152-1
10.1002/mds.25361
10.1002/mds.27094
10.1016/j.neuroimage.2008.01.056
10.3233/JPD-150583
10.1007/s11910-017-0738-x
10.1523/JNEUROSCI.4188-09.2010
10.1007/s00259-012-2198-5
10.1002/ana.23631
10.1016/j.tins.2009.06.003
10.1212/WNL.0000000000000130
10.1016/j.nicl.2014.06.007
10.1016/S1474-4422(13)70054-1
10.1212/WNL.0b013e3182886a76
10.1016/S1474-4422(13)70056-5
10.1212/WNL.0b013e318278b658
10.1073/pnas.1411011112
10.1212/01.wnl.0000340980.19702.6e
10.2967/jnumed.111.089946
10.1002/mds.23721
10.1038/srep40779
10.1002/mds.26424
10.1016/j.parkreldis.2013.02.013
10.1038/sj.jcbfm.9600358
10.1002/ana.24385
10.1016/j.sleep.2012.10.009
10.1073/pnas.1206247109
10.1007/s12021-014-9235-4
10.1016/S0197-4580(02)00065-9
10.1016/j.tins.2014.02.009
10.1016/j.neuroimage.2010.10.025
10.1038/jcbfm.1994.99
10.1016/j.parkreldis.2016.05.031
10.3389/fnsys.2011.00031
10.1109/TAC.1974.1100705
10.1093/brain/awn075
10.1002/mds.26431
10.1016/j.sleep.2010.12.009
10.1093/brain/aws093
10.1371/journal.pone.0089741
10.1093/brain/awu290
10.1212/WNL.0b013e3182315259
10.1007/s00221-013-3621-2
10.1016/S1474-4422(10)70216-7
10.1007/s00415-011-6149-z
10.1038/jcbfm.2015.173
ContentType Journal Article
Contributor Timmermann, Lars
Adriaanse, Sofie M
Kesper, Karl
Girtler, Nicola
Depboylu, Candan
Sambuceti, Gianmario
Reetz, Kathrin
Luster, Marcus
Booij, Jan
Reesink, Fransje E
Sittig-Wiegand, Elisabeth
Overeem, Sebastiaan
Höffken, Helmut
Pijpers, Angelique
van Laar, Teus
Teune, Laura K
Jonsson, Cathrine
Contributor_xml – sequence: 1
  givenname: Elisabeth
  surname: Sittig-Wiegand
  fullname: Sittig-Wiegand, Elisabeth
– sequence: 2
  givenname: Candan
  surname: Depboylu
  fullname: Depboylu, Candan
– sequence: 3
  givenname: Kathrin
  surname: Reetz
  fullname: Reetz, Kathrin
– sequence: 4
  givenname: Sebastiaan
  surname: Overeem
  fullname: Overeem, Sebastiaan
– sequence: 5
  givenname: Angelique
  surname: Pijpers
  fullname: Pijpers, Angelique
– sequence: 6
  givenname: Fransje E
  surname: Reesink
  fullname: Reesink, Fransje E
– sequence: 7
  givenname: Teus
  surname: van Laar
  fullname: van Laar, Teus
– sequence: 8
  givenname: Laura K
  surname: Teune
  fullname: Teune, Laura K
– sequence: 9
  givenname: Helmut
  surname: Höffken
  fullname: Höffken, Helmut
– sequence: 10
  givenname: Marcus
  surname: Luster
  fullname: Luster, Marcus
– sequence: 11
  givenname: Lars
  surname: Timmermann
  fullname: Timmermann, Lars
– sequence: 12
  givenname: Karl
  surname: Kesper
  fullname: Kesper, Karl
– sequence: 13
  givenname: Sofie M
  surname: Adriaanse
  fullname: Adriaanse, Sofie M
– sequence: 14
  givenname: Jan
  surname: Booij
  fullname: Booij, Jan
– sequence: 15
  givenname: Gianmario
  surname: Sambuceti
  fullname: Sambuceti, Gianmario
– sequence: 16
  givenname: Nicola
  surname: Girtler
  fullname: Girtler, Nicola
– sequence: 17
  givenname: Cathrine
  surname: Jonsson
  fullname: Jonsson, Cathrine
Copyright 2018 by the Society of Nuclear Medicine and Molecular Imaging.
Copyright Society of Nuclear Medicine Sep 1, 2018
Copyright_xml – notice: 2018 by the Society of Nuclear Medicine and Molecular Imaging.
– notice: Copyright Society of Nuclear Medicine Sep 1, 2018
CorporateAuthor the REMPET Study Group
REMPET Study Group
CorporateAuthor_xml – name: the REMPET Study Group
– name: REMPET Study Group
DBID AAYXX
CITATION
NPM
4T-
8FD
FR3
K9.
M7Z
NAPCQ
P64
7X8
ADTOC
UNPAY
DOI 10.2967/jnumed.117.202242
DatabaseName CrossRef
PubMed
Docstoc
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biochemistry Abstracts 1
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
PubMed
Nursing & Allied Health Premium
Technology Research Database
Docstoc
Biochemistry Abstracts 1
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Nursing & Allied Health Premium
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2159-662X
1535-5667
EndPage 1444
ExternalDocumentID 10.2967/jnumed.117.202242
29476004
10_2967_jnumed_117_202242
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 123
18M
41~
5VS
96U
AAYXX
ACGFO
AEGXH
AIAGR
ALMA_UNASSIGNED_HOLDINGS
CITATION
GX1
N9A
RHI
TSM
U5U
W8F
---
-~X
.55
.GJ
29L
2WC
3O-
53G
5RE
7RV
7X7
88E
88I
8AF
8AO
8FE
8FG
8FH
8FI
8FJ
8R4
8R5
8WZ
A6W
ABEFU
ABSQV
ABUWG
ACGOD
ACIWK
ACPRK
ADDZX
ADMOG
AENEX
AFFNX
AFKRA
AFOSN
AFRAH
AHMBA
AI.
ALIPV
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
CCPQU
CS3
DIK
DU5
DWQXO
E3Z
EBD
EBS
EJD
EMOBN
EX3
F5P
F9R
FYUFA
GNUQQ
H13
HCIFZ
HMCUK
I-F
IL9
INIJC
J5H
KQ8
L7B
LK8
M1P
M2P
M2Q
M7P
N4W
NAPCQ
NPM
OK1
P2P
P62
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
R0Z
RNS
RWL
S0X
SJN
SV3
TAE
TR2
TUS
UKHRP
VH1
WH7
WOQ
WOW
X7M
YHG
YQJ
ZGI
ZXP
4T-
8FD
FR3
K9.
M7Z
P64
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c372t-5619baf7f11d926bd68948a717dc0ae3b2399542f86da7363aaafee0c9462d7c3
IEDL.DBID UNPAY
ISSN 0161-5505
1535-5667
2159-662X
IngestDate Sun Oct 26 03:31:21 EDT 2025
Thu Oct 02 08:34:42 EDT 2025
Mon Oct 06 18:24:31 EDT 2025
Mon Jul 21 05:58:14 EDT 2025
Tue Jul 01 01:45:19 EDT 2025
Thu Apr 24 23:12:23 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Neurology
metabolic pattern
statistical
18F-FDG-PET
idiopathic REM
PET/CT
α-synucleinopathy
Parkinson’s disease related pattern
sleep behavior disorder
analysis
Language English
License 2018 by the Society of Nuclear Medicine and Molecular Imaging.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c372t-5619baf7f11d926bd68948a717dc0ae3b2399542f86da7363aaafee0c9462d7c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://proxy.k.utb.cz/login?url=http://jnm.snmjournals.org/content/59/9/1437.full.pdf
PMID 29476004
PQID 2126563128
PQPubID 40808
PageCount 8
ParticipantIDs unpaywall_primary_10_2967_jnumed_117_202242
proquest_miscellaneous_2007982936
proquest_journals_2126563128
pubmed_primary_29476004
crossref_primary_10_2967_jnumed_117_202242
crossref_citationtrail_10_2967_jnumed_117_202242
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-09-00
20180901
PublicationDateYYYYMMDD 2018-09-01
PublicationDate_xml – month: 09
  year: 2018
  text: 2018-09-00
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
PublicationTitle Journal of Nuclear Medicine
PublicationTitleAlternate J Nucl Med
PublicationYear 2018
Publisher Society of Nuclear Medicine
Publisher_xml – name: Society of Nuclear Medicine
References Meles (2021051712122534000_59.9.1437.21) 2017; 32
2021051712122534000_59.9.1437.30
2021051712122534000_59.9.1437.31
2021051712122534000_59.9.1437.12
2021051712122534000_59.9.1437.34
2021051712122534000_59.9.1437.13
2021051712122534000_59.9.1437.35
2021051712122534000_59.9.1437.10
Zhu (2021051712122534000_59.9.1437.28) 2017; 7
2021051712122534000_59.9.1437.32
2021051712122534000_59.9.1437.11
2021051712122534000_59.9.1437.33
2021051712122534000_59.9.1437.17
2021051712122534000_59.9.1437.39
2021051712122534000_59.9.1437.14
2021051712122534000_59.9.1437.36
2021051712122534000_59.9.1437.15
2021051712122534000_59.9.1437.37
2021051712122534000_59.9.1437.18
Delaville (2021051712122534000_59.9.1437.38) 2011; 5
2021051712122534000_59.9.1437.19
Boeve (2021051712122534000_59.9.1437.7) 2013; 12
2021051712122534000_59.9.1437.9
2021051712122534000_59.9.1437.8
Fereshtehnejad (2021051712122534000_59.9.1437.22) 2017; 17
2021051712122534000_59.9.1437.6
2021051712122534000_59.9.1437.5
Arnaldi (2021051712122534000_59.9.1437.23) 2016; 29
2021051712122534000_59.9.1437.41
Teune (2021051712122534000_59.9.1437.16) 2014; 5
2021051712122534000_59.9.1437.20
2021051712122534000_59.9.1437.42
2021051712122534000_59.9.1437.40
2021051712122534000_59.9.1437.45
2021051712122534000_59.9.1437.24
2021051712122534000_59.9.1437.46
2021051712122534000_59.9.1437.43
2021051712122534000_59.9.1437.44
2021051712122534000_59.9.1437.4
2021051712122534000_59.9.1437.27
2021051712122534000_59.9.1437.3
2021051712122534000_59.9.1437.2
2021051712122534000_59.9.1437.25
2021051712122534000_59.9.1437.47
2021051712122534000_59.9.1437.1
2021051712122534000_59.9.1437.26
2021051712122534000_59.9.1437.48
2021051712122534000_59.9.1437.29
References_xml – ident: 2021051712122534000_59.9.1437.34
  doi: 10.1016/j.neuroimage.2009.06.012
– ident: 2021051712122534000_59.9.1437.41
  doi: 10.1212/01.wnl.0000242879.39415.49
– ident: 2021051712122534000_59.9.1437.31
  doi: 10.1016/S1474-4422(11)70152-1
– ident: 2021051712122534000_59.9.1437.17
  doi: 10.1002/mds.25361
– volume: 32
  start-page: 1482
  year: 2017
  ident: 2021051712122534000_59.9.1437.21
  article-title: FDG PET, dopamine transporter SPECT, and olfaction: combining biomarkers in REM sleep behavior disorder
  publication-title: Mov Disord.
  doi: 10.1002/mds.27094
– ident: 2021051712122534000_59.9.1437.27
  doi: 10.1016/j.neuroimage.2008.01.056
– ident: 2021051712122534000_59.9.1437.45
  doi: 10.3233/JPD-150583
– volume: 17
  start-page: 34
  year: 2017
  ident: 2021051712122534000_59.9.1437.22
  article-title: Subtypes of parkinson's disease: what do they tell us about disease progression?
  publication-title: Curr Neurol Neurosci Rep.
  doi: 10.1007/s11910-017-0738-x
– ident: 2021051712122534000_59.9.1437.29
  doi: 10.1523/JNEUROSCI.4188-09.2010
– ident: 2021051712122534000_59.9.1437.47
  doi: 10.1007/s00259-012-2198-5
– ident: 2021051712122534000_59.9.1437.15
  doi: 10.1002/ana.23631
– ident: 2021051712122534000_59.9.1437.11
  doi: 10.1016/j.tins.2009.06.003
– ident: 2021051712122534000_59.9.1437.19
  doi: 10.1212/WNL.0000000000000130
– volume: 5
  start-page: 240
  year: 2014
  ident: 2021051712122534000_59.9.1437.16
  article-title: Parkinson’s disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging
  publication-title: Neuroimage Clin.
  doi: 10.1016/j.nicl.2014.06.007
– volume: 12
  start-page: 469
  year: 2013
  ident: 2021051712122534000_59.9.1437.7
  article-title: Idiopathic REM sleep behaviour disorder in the development of Parkinson’s disease
  publication-title: Lancet Neurol.
  doi: 10.1016/S1474-4422(13)70054-1
– ident: 2021051712122534000_59.9.1437.37
  doi: 10.1212/WNL.0b013e3182886a76
– ident: 2021051712122534000_59.9.1437.3
  doi: 10.1016/S1474-4422(13)70056-5
– ident: 2021051712122534000_59.9.1437.40
  doi: 10.1212/WNL.0b013e318278b658
– ident: 2021051712122534000_59.9.1437.48
  doi: 10.1073/pnas.1411011112
– ident: 2021051712122534000_59.9.1437.1
  doi: 10.1212/01.wnl.0000340980.19702.6e
– ident: 2021051712122534000_59.9.1437.44
  doi: 10.2967/jnumed.111.089946
– ident: 2021051712122534000_59.9.1437.42
  doi: 10.1002/mds.23721
– volume: 7
  start-page: 40779
  year: 2017
  ident: 2021051712122534000_59.9.1437.28
  article-title: Clinical variations in Parkinson’s disease patients with or without REM sleep behaviour disorder: a meta-analysis
  publication-title: Sci Rep.
  doi: 10.1038/srep40779
– ident: 2021051712122534000_59.9.1437.10
  doi: 10.1002/mds.26424
– ident: 2021051712122534000_59.9.1437.18
  doi: 10.1016/j.parkreldis.2013.02.013
– ident: 2021051712122534000_59.9.1437.14
  doi: 10.1038/sj.jcbfm.9600358
– ident: 2021051712122534000_59.9.1437.6
  doi: 10.1002/ana.24385
– ident: 2021051712122534000_59.9.1437.4
  doi: 10.1016/j.sleep.2012.10.009
– ident: 2021051712122534000_59.9.1437.33
  doi: 10.1073/pnas.1206247109
– ident: 2021051712122534000_59.9.1437.25
  doi: 10.1007/s12021-014-9235-4
– ident: 2021051712122534000_59.9.1437.8
  doi: 10.1016/S0197-4580(02)00065-9
– ident: 2021051712122534000_59.9.1437.32
  doi: 10.1016/j.tins.2014.02.009
– ident: 2021051712122534000_59.9.1437.12
  doi: 10.1016/j.neuroimage.2010.10.025
– ident: 2021051712122534000_59.9.1437.13
  doi: 10.1038/jcbfm.1994.99
– volume: 29
  start-page: 47
  year: 2016
  ident: 2021051712122534000_59.9.1437.23
  article-title: Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson’s disease and probable RBD
  publication-title: Parkinsonism Relat Disord.
  doi: 10.1016/j.parkreldis.2016.05.031
– volume: 5
  start-page: 31
  year: 2011
  ident: 2021051712122534000_59.9.1437.38
  article-title: Noradrenaline and Parkinson’s disease
  publication-title: Front Syst Neurosci.
  doi: 10.3389/fnsys.2011.00031
– ident: 2021051712122534000_59.9.1437.26
  doi: 10.1109/TAC.1974.1100705
– ident: 2021051712122534000_59.9.1437.35
  doi: 10.1093/brain/awn075
– ident: 2021051712122534000_59.9.1437.9
  doi: 10.1002/mds.26431
– ident: 2021051712122534000_59.9.1437.24
  doi: 10.1016/j.sleep.2010.12.009
– ident: 2021051712122534000_59.9.1437.2
  doi: 10.1093/brain/aws093
– ident: 2021051712122534000_59.9.1437.5
  doi: 10.1371/journal.pone.0089741
– ident: 2021051712122534000_59.9.1437.20
  doi: 10.1093/brain/awu290
– ident: 2021051712122534000_59.9.1437.46
  doi: 10.1212/WNL.0b013e3182315259
– ident: 2021051712122534000_59.9.1437.39
  doi: 10.1007/s00221-013-3621-2
– ident: 2021051712122534000_59.9.1437.30
  doi: 10.1016/S1474-4422(10)70216-7
– ident: 2021051712122534000_59.9.1437.36
  doi: 10.1007/s00415-011-6149-z
– ident: 2021051712122534000_59.9.1437.43
  doi: 10.1038/jcbfm.2015.173
SSID ssj0006888
ssj0062072
Score 2.5427806
Snippet Idiopathic REM sleep behavior disorder (iRBD) is considered a prodromal stage of Parkinson disease (PD) and other Lewy body disorders. Spatial covariance...
SourceID unpaywall
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1437
SubjectTerms Brain diseases
Brain stem
Cerebellum
Cognition
Cognitive ability
Correlation analysis
Cortex (parietal)
Covariance
Glucose metabolism
Hypometabolism
Identification methods
Lewy bodies
Metabolic disorders
Metabolism
Movement disorders
Neurodegenerative diseases
Occipital lobe
Parkinson's disease
Patients
Positron emission
Positron emission tomography
REM sleep
Sleep
Sleep disorders
Somatosensory cortex
Statistical analysis
Temporal lobe
Thalamus
Tomography
Title The Metabolic Pattern of Idiopathic REM Sleep Behavior Disorder Reflects Early-Stage Parkinson Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/29476004
https://www.proquest.com/docview/2126563128
https://www.proquest.com/docview/2007982936
http://jnm.snmjournals.org/content/59/9/1437.full.pdf
UnpaywallVersion publishedVersion
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2159-662X
  dateEnd: 20250505
  omitProxy: true
  ssIdentifier: ssj0006888
  issn: 0161-5505
  databaseCode: KQ8
  dateStart: 19640101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2159-662X
  dateEnd: 20241105
  omitProxy: true
  ssIdentifier: ssj0006888
  issn: 0161-5505
  databaseCode: DIK
  dateStart: 19640101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2159-662X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0062072
  issn: 0161-5505
  databaseCode: GX1
  dateStart: 0
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwEB612wPiAEW8gkplJE6gZLOO49jHCrVqi7YqhUXLKfKzKqTZVTcrBL-ecR4rqkqgnuM8Z5zvs2fmG4C3qZWFFzRkNxgds6CsLbizsbS504iwuaah3nl6xo9n7HSez7dg6FT4vb5OVvV1_x1XbSg_5GzjD3icy7EcI7wXSdiZTpbWb8MOz5GCj2BndnZ-8C00kkN4jjmn8y6CSSUv8KI4zW0IT-J6ECGL3sagO8TyITxY10v166eqqr_A5ugxfB1Kdrockx_JutGJ-X1XwfF-77ELj3r6SQ46f3kCW65-Ch59hUxdg_5QXRly3kpu1mThyYm9WrQ9iw25OJySz5VzS9JLKt6QQbmTXDgfdv9XpJVLjpHAXjoS6qnb0rIwLgSBnsHs6PDLh-O4778Qm6ygTYzUSmrlCz-ZWEm5tlxIJhQuAK1Jlct0WxfLqBfcqiLjmVLKO5cayTi1hcmew6he1O4lkFwYLRkLUjATpr2VKje5o16mkiqhJxGkg0VK04uThx4ZVYmLlGDEsjNi0CYvOyNG8G5zyrJT5vjX4L3BzOVglBJRG9lshggdwZvNYZxeIWaiardYr0KXzkIK5EQ8ghede2zuRiULYU0WwfuNv_z_UV7da_QejJqbtXuNzKfR-7D98ZPY7739Dzc4Bw4
linkProvider Unpaywall
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9NAEB6V9IA48BAvo4IWiRPIjrNer73HCrUqSKmqQlA4WfusCq4TNY4Q_Hpm_IhAlUA9e_2cWX_f7sx8A_AmdaoIJafsBmtiQcrapfQuVi73BhE2N5zqneen8mQhPi7z5R6MnQq_NVfJprkavuOmC-VTzjb-gKe5mqopwnuR0M50snbhDuzLHCn4BPYXp2eHX6mRHMJzLCVf9hFMrmSBF8Vp7ig8ietBhCz-NwbdIJb34O62WeufP3Rd_wE2xw_gy1iy0-eYfE-2rUnsr5sKjrd7j4dwf6Cf7LD3l0ew55vHENBX2Ny36A_1pWVnneRmw1aBfXCXq65nsWXnR3P2qfZ-zQZJxWs2Kneycx9o93_DOrnkGAnshWdUT92VltE4CgI9gcXx0ef3J_HQfyG2WcHbGKmVMjoUYTZzikvjZKlEqXEB6GyqfWa6uljBQymdLjKZaa2D96lVQnJX2OwpTJpV458Dy0trlBAkBTMTJjilc5t7HlSquC7NLIJ0tEhlB3Fy6pFRV7hIISNWvRFJm7zqjRjB290p616Z41-DD0YzV6NRKkRtZLMZInQEr3eHcXpRzEQ3frXdUJfOQpXIiWQEz3r32N2NK0FhTRHBu52__P9RXtxq9AFM2uutf4nMpzWvBj__DRKfBhk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Metabolic+Pattern+of+Idiopathic+REM+Sleep+Behavior+Disorder+Reflects+Early-Stage+Parkinson+Disease&rft.jtitle=Journal+of+Nuclear+Medicine&rft.au=Meles%2C+Sanne+K.&rft.au=Renken%2C+Remco+J.&rft.au=Janzen%2C+Annette&rft.au=Vadasz%2C+David&rft.date=2018-09-01&rft.issn=0161-5505&rft.eissn=2159-662X&rft.volume=59&rft.issue=9&rft.spage=1437&rft.epage=1444&rft_id=info:doi/10.2967%2Fjnumed.117.202242&rft.externalDBID=n%2Fa&rft.externalDocID=10_2967_jnumed_117_202242
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0161-5505&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0161-5505&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0161-5505&client=summon